NOTV - Inotiv, Inc.


0.2701
-0.003   -1.074%

Share volume: 274,018
Last Updated: 03-27-2026
Business Services/Services – Research, Development, Testing Labs: -0.05%

PREVIOUS CLOSE
CHG
CHG%

$0.27
0.00
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
32%
Profitability 35%
Dept financing 42%
Liquidity 15%
Performance 30%
Company vs Stock growth
vs
Performance
5 Days
-17.32%
1 Month
-11.73%
3 Months
-48.43%
6 Months
-80.84%
1 Year
-87.44%
2 Year
-97.53%
Key data
Stock price
$0.27
P/E Ratio 
0.00
DAY RANGE
$0.27 - $0.30
EPS 
-$1.92
52 WEEK RANGE
$0.25 - $3.32
52 WEEK CHANGE
-$87.78
MARKET CAP 
14.407 M
YIELD 
N/A
SHARES OUTSTANDING 
34.395 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-09-2025
BETA 
4.50
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$379,372
AVERAGE 30 VOLUME 
$490,253
Company detail
CEO: Robert Leasure
Region: US
Website: inotivco.com
Employees: 2,100
IPO year: 1997
Issue type: Common Stock
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

Inotiv, Inc. provides drug discovery and development services to pharmaceutical, chemical, and medical device industries. It operates through two segments, Contract Research Services and Research Products. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally.

Recent news